指南与共识神经MRPET

多发性硬化中神经保护与修复的影像学结局指标:北美多发性硬化影像协作组(NAIMS)共识声明

Imaging outcome measures of neuroprotection and repair in MS: A consensus statement from NAIMS.
指南 / 共识 · Neurology · 2019-02-20

北美多发性硬化影像协作组(NAIMS)于2016年11月在加拿大多伦多召开研讨会,总结用于评估多发性硬化神经保护与修复的现有及新兴影像技术,并就每种技术在临床试验中的潜在效用达成共识意见;结论指出神经保护与修复的影像生物标志物仍是未满足需求,技术选择取决于试验所要回答的问题。

要点

  • 常规影像、磁化传递率、扩散张量成像、磁敏感加权成像、皮质病灶成像、磁共振波谱、PET、先进扩散成像、钠成像及多模态技术等均可用于评估神经保护与修复。
  • 每种技术各有优势与局限,具体选择取决于试验所要回答的问题。
  • 神经保护与修复的影像生物标志物在多发性硬化中仍是未满足的需求。

核心结论

  • 神经保护与修复的影像生物标志物在多发性硬化中仍是未满足的需求;多种有前景的技术各有不同优势与局限,具体选择取决于多项因素,尤其是试验所要回答的问题。

研究设计与样本

  • 北美多发性硬化影像协作组(NAIMS)协作研讨会共识声明;2016年11月在加拿大多伦多召开,由具有多发性硬化MRI应用专长的临床医生和科学家讨论,整理成稿后经全体出席的NAIMS成员传阅并修订反馈直至全体作者一致同意。

诊断标准与关键数值

  • 讨论在特定研究设计背景下涵盖常规成像、磁化传递率、扩散张量成像、磁敏感加权成像、皮质病灶成像、磁共振波谱、PET、先进扩散成像、钠成像、多模态技术、特殊区域成像、统计学考量与研究设计等主题。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To summarize current and emerging imaging techniques that can be used to assess neuroprotection and repair in multiple sclerosis (MS), and to provide a consensus opinion on the potential utility of each technique in clinical trial settings.

METHODS: Clinicians and scientists with expertise in the use of MRI in MS convened in Toronto, Canada, in November 2016 at a North American Imaging in Multiple Sclerosis (NAIMS) Cooperative workshop meeting. The discussion was compiled into a manuscript and circulated to all NAIMS members in attendance. Edits and feedback were incorporated until all authors were in agreement.

RESULTS: A wide spectrum of imaging techniques and analysis methods in the context of specific study designs were discussed, with a focus on the utility and limitations of applying each technique to assess neuroprotection and repair. Techniques were discussed under specific themes, and included conventional imaging, magnetization transfer ratio, diffusion tensor imaging, susceptibility-weighted imaging, imaging cortical lesions, magnetic resonance spectroscopy, PET, advanced diffusion imaging, sodium imaging, multimodal techniques, imaging of special regions, statistical considerations, and study design.

CONCLUSIONS: Imaging biomarkers of neuroprotection and repair are an unmet need in MS. There are a number of promising techniques with different strengths and limitations, and selection of a specific technique will depend on a number of factors, notably the question the trial seeks to answer. Ongoing collaborative efforts will enable further refinement and improved methods to image the effect of novel therapeutic agents that exert benefit in MS predominately through neuroprotective and reparative mechanisms.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Oh J, Ontaneda D, Azevedo C, et al. Imaging outcome measures of neuroprotection and repair in MS: A consensus statement from NAIMS. Neurology. 2019. PMID: 30787160. doi:10.1212/WNL.0000000000007099

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。